| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.099 | 0.03 |